A Home-based Rehabilitation in ARSACS (PACE-ARSCS)
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
About this trial
This is an interventional supportive care trial for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay focused on measuring ARSACS
Eligibility Criteria
Inclusion Criteria: ARSACS diagnosis must be confirmed by genetic analysis; Women and men, aged between 18 and 50 years old; Be able to perform the sit-to-stand transfer; Consent of the neurologist must be given to participate in this study; Must reside in the Saguenay-Lac-St-Jean region; Subjects must be able to give their consent freely and voluntarily. Exclusion Criteria: Patients who already meet physical activity (PA) recommendations (150 min of moderate to high intensity PA/week) or already participate in a rehabilitation program are excluded; Remain in a care facility; Do not speak English or French; Have another diagnosis causing physical limitations; Are pregnant.
Sites / Locations
- Groupe de recherche interdisciplinaire sur les maladies neuromusculairesRecruiting
Arms of the Study
Arm 1
Experimental
Control followed by intervention phase
All participants will participate in 2 phases : control phase (12-week usual care) followed by an intervention phase (12-week home-based rehabilitation program). The rehabilitation program consists of three domains of exercises divided by levels of difficulty: sitting balance (16 levels), standing balance (21 levels) and sit-to-stand transfer (12 levels), including 67 exercises. Each individualized home-based rehabilitation program will include 3 to 6 exercises, for a total duration of 15 to 20 minutes.